Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
An evaluation of a real-world, multi-disciplinary, treatment-free remission programme for patients with Chronic Myeloid Leukaemia.
Eleanor Jones, Joanne Ewing, Hayder Hussein, Bernard Maybury, Manoj Raghavan, Julie Suhr, Nick Duncan
Published: 202510.1177/10781552251384611
Abstract
IntroductionThe management of chronic myeloid leukaemia (CML) has been revolutionized by the introduction of imatinib and other tyrosine kinase inhibitors (TKIs). Despite excellent efficacy, patient quality of life is often negatively affected by TKI…
Preview only. Read the full abstract at the source